Naveris Acquired by CareDx | Healthcare M&A Deal

CareDx has agreed to acquire Naveris, a diagnostics imaging business in California. Naveris provides viral-mediated cancer MRD surveillance testing, supporting oncology monitoring through sensitive detection of minimal residual disease. CareDx acquisitions in diagnostics imaging aim to expand MRD testing capabilities and strengthen healthcare M&A positioning in cancer diagnostics. The Naveris acquisition is structured as an add on acquisition, aligning with a private equity acquisition strategy by CareDx, with deal size undisclosed and status announced.